pomalidomide has been researched along with alectinib in 1 studies
| Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (alectinib) | Trials (alectinib) | Recent Studies (post-2010) (alectinib) |
|---|---|---|---|---|---|
| 623 | 121 | 552 | 446 | 51 | 433 |
| Protein | Taxonomy | pomalidomide (IC50) | alectinib (IC50) |
|---|---|---|---|
| Cyclin-G-associated kinase | Homo sapiens (human) | 0.01 | |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 0.0197 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 1.4 | |
| SRSF protein kinase 1 | Homo sapiens (human) | 0.195 | |
| Echinoderm microtubule-associated protein-like 4 | Homo sapiens (human) | 0.0682 | |
| ALK tyrosine kinase receptor | Homo sapiens (human) | 0.0748 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZS; Li, X; Liu, Y; Sun, Y; Xie, S; Xu, J; Xu, S; Yang, DH; Yao, H; Zhan, F; Zhong, W; Zhu, J | 1 |
1 other study(ies) available for pomalidomide and alectinib
| Article | Year |
|---|---|
Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK).
Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Development; Drug Screening Assays, Antitumor; Humans; Mice; Molecular Structure; Neoplasms, Experimental; Piperidines; Protein Kinase Inhibitors; Proteolysis; Rats; Structure-Activity Relationship | 2021 |